Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For lymphoma survivors (Phase 1 and Phase 2):
- People who have been diagnosed with lymphoma (including indolent non-Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or classic Hodgkin lymphoma)
- People aged 18 or older
- People who finished their first course of treatment between 3 and 24 months ago
- People whose lymphoma is in complete remission after their first course of treatment
- People experiencing a clinically significant level of fear that their cancer may return, as measured by a specific validated questionnaire (a score of 16 or higher on the FCRI-SS scale)
- People who have access to a computer that can be used for video calls
For lymphoma doctors and mental health clinicians (Phase 1 only):
- Lymphoma doctors who completed their oncology specialist training at least 1 year ago, or mental health clinicians (such as psychologists, social workers, or psychiatrists) who completed their clinical training at least 1 year ago
- Oncologists who provide ongoing care for patients with lymphoma, or mental health clinicians who provide care for people with cancer
Who may not be able to join:
- People under the age of 18
- People currently diagnosed with another cancer at the same time
- People with a psychotic disorder, bipolar disorder, or borderline personality disorder that is currently untreated or uncontrolled (as determined through a medical record review)
- People who are not able to provide their own informed consent
- Children, teenagers, or infants
- Women who are pregnant
- People who are currently in prison
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Oreofe O Odejide, MD, PhD, Oreofe_Odejide@dfci.harvard.edu
Phone: (617) 632-6864
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility: Enrollment Rate; Feasibility: Program Session Completion Rate; Feasibility: Data Collection Completion Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.